About David P Meeker
Meeker is the Chairman, President & CEO of Rhythm Therapeutics, a biotechnology company focused on developing innovative therapies for rare genetic disorders of obesity. Dr. Meeker was formerly the President and CEO of Genzyme, a Sanofi company, a position he assumed when Genzyme merged with Sanofi in 2011.